Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Prostate Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

Biomarker Study to Determine Frequency of DNA-repair Defects in Men with Metastatic Prostate Cancer (64091742PCR0002)

  • Details

ClinicalTrials.gov ID: NCT03871816
Diagnosis Type: NA
USOR Number: 19144

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (888) 384-9822

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

QBGJ398-302: Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects with Invasive Urothelial Carcinoma with Susceptible FGFR3 Genetic Alterations (PROOF302)

  • Details

ClinicalTrials.gov ID: NCT04197986
Diagnosis Type: NA
USOR Number: 19094

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (888) 384-9822

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: NA
USOR Number: 19032

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (888) 384-9822

More Details View Practice Page

Lung Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Randomized, Double-Blind, Phase 3 Study of Pemetrexed + PlatinumChemotherapy with or without Pembrolizumab (MK-3475) in TKI-resistant EGFR-mutated Tumors in Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) Participants (KEYNOTE-789; MK-3475-789)

  • Details

ClinicalTrials.gov ID: NCT03515837
Diagnosis Type: NA
USOR Number: 19020

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (888) 384-9822

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: NA
USOR Number: 18264

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (888) 384-9822

More Details View Practice Page

Lymphomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

AN OPEN-LABEL, MULTICENTER, PHASE I/IB TRIAL EVALUATING THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF ESCALATING DOSES OF MOSUNETUZUMAB (BTCT4465A) AS A SINGLE AGENT AND COMBINED WITH ATEZOLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA (GO29781)

  • Details

ClinicalTrials.gov ID: NCT02500407
Diagnosis Type: Non-Hodgkins
USOR Number: 18187

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (888) 384-9822

More Details View Practice Page

Leukemia

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 3b, Single-Arm, Multicenter Open-Label Study of Venetoclax in Combination with Azacitidine or Decitabine in an Outpatient Setting in AML Patients Ineligible for Intensive Chemotherapy (M19-072)

  • Details

ClinicalTrials.gov ID: NCT03941964
Diagnosis Type: AML
USOR Number: 18168

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (888) 384-9822

More Details View Practice Page

Lung Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

Brigatinib-3001- A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIG®)Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer Patients Who Have Progressed on Crizotinib (XALKORI®)

  • Details

ClinicalTrials.gov ID: NCT03596866
Diagnosis Type: NA
USOR Number: 18129

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (888) 384-9822

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (888) 384-9822

More Details View Practice Page

Lymphomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

Treatment Patterns, Outcomes, and Patient-Reported Health-RelatedQuality of Life: A Prospective Disease Registry of Patients with Mantle Cell Lymphoma Treated with Novel Agents (D8220R00004)

  • Details

ClinicalTrials.gov ID: NCT03816683
Diagnosis Type: NA
USOR Number: 18127

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (888) 384-9822

More Details View Practice Page
1 2 3 4